Literature DB >> 21082368

The blood-cerebrospinal fluid barrier: structure and functional significance.

Conrad E Johanson1, Edward G Stopa, Paul N McMillan.   

Abstract

The choroid plexus (CP) of the blood-CSF barrier (BCSFB) displays fundamentally different properties than blood-brain barrier (BBB). With brisk blood flow (10 × brain) and highly permeable capillaries, the human CP provides the CNS with a high turnover rate of fluid (∼400,000 μL/day) containing micronutrients, peptides, and hormones for neuronal networks. Renal-like basement membranes in microvessel walls and underneath the epithelium filter large proteins such as ferritin and immunoglobulins. Type IV collagen (α3, α4, and α5) in the subepithelial basement membrane confers kidney-like permselectivity. As in the glomerulus, so also in CP, the basolateral membrane utrophin A and colocalized dystrophin impart structural stability, transmembrane signaling, and ion/water homeostasis. Extensive infoldings of the plasma-facing basal labyrinth together with lush microvilli at the CSF-facing membrane afford surface area, as great as that at BBB, for epithelial solute and water exchange. CSF formation occurs by basolateral carrier-mediated uptake of Na+, Cl-, and HCO3-, followed by apical release via ion channel conductance and osmotic flow of water through AQP1 channels. Transcellular epithelial active transport and secretion are energized and channeled via a highly dense organelle network of mitochondria, endoplasmic reticulum, and Golgi; bleb formation occurs at the CSF surface. Claudin-2 in tight junctions helps to modulate the lower electrical resistance and greater permeability in CP than at BBB. Still, ratio analyses of influx coefficients (Kin) for radiolabeled solutes indicate that paracellular diffusion of small nonelectrolytes (e.g., urea and mannitol) through tight junctions is restricted; molecular sieving is proportional to solute size. Protein/peptide movement across BCSFB is greatly limited, occurring by paracellular leaks through incomplete tight junctions and low-capacity transcellular pinocytosis/exocytosis. Steady-state concentration ratios, CSF/plasma, ranging from 0.003 for IgG to 0.80 for urea, provide insight on plasma solute penetrability, barrier permeability, and CSF sink action to clear substances from CNS.

Entities:  

Mesh:

Year:  2011        PMID: 21082368     DOI: 10.1007/978-1-60761-938-3_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  70 in total

1.  Beta-catenin signaling regulates barrier-specific gene expression in circumventricular organ and ocular vasculatures.

Authors:  Yanshu Wang; Mark F Sabbagh; Xiaowu Gu; Amir Rattner; John Williams; Jeremy Nathans
Journal:  Elife       Date:  2019-04-01       Impact factor: 8.140

Review 2.  Towards nanomedicines for neuroAIDS.

Authors:  Vidya Sagar; Sudheesh Pilakka-Kanthikeel; Ravi Pottathil; Shailendra K Saxena; Madhavan Nair
Journal:  Rev Med Virol       Date:  2014-01-07       Impact factor: 6.989

Review 3.  Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

Authors:  Lucy Sanchez-Covarrubias; Lauren M Slosky; Brandon J Thompson; Thomas P Davis; Patrick T Ronaldson
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

4.  Blood-CNS barrier, neurodegeneration and neuroprotection: recent therapeutic advancements and nano-drug delivery.

Authors:  Hari S Sharma
Journal:  J Neural Transm (Vienna)       Date:  2011-01       Impact factor: 3.575

Review 5.  Aging and Rejuvenation of Neural Stem Cells and Their Niches.

Authors:  Paloma Navarro Negredo; Robin W Yeo; Anne Brunet
Journal:  Cell Stem Cell       Date:  2020-07-28       Impact factor: 24.633

Review 6.  The blood brain barrier and neuropsychiatric lupus: new perspectives in light of advances in understanding the neuroimmune interface.

Authors:  Ariel D Stock; Sivan Gelb; Ofer Pasternak; Ayal Ben-Zvi; Chaim Putterman
Journal:  Autoimmun Rev       Date:  2017-04-17       Impact factor: 9.754

7.  Neutralizing anti-interleukin-1β antibodies modulate fetal blood-brain barrier function after ischemia.

Authors:  Xiaodi Chen; Grazyna B Sadowska; Jiyong Zhang; Jeong-Eun Kim; Erin E Cummings; Courtney A Bodge; Yow-Pin Lim; Oleksandr Makeyev; Walter G Besio; John Gaitanis; Steven W Threlkeld; William A Banks; Barbara S Stonestreet
Journal:  Neurobiol Dis       Date:  2014-09-26       Impact factor: 5.996

8.  Two Diverse Hemodynamic Forces, a Mechanical Stretch and a High Wall Shear Stress, Determine Intracranial Aneurysm Formation.

Authors:  Hirokazu Koseki; Haruka Miyata; Satoshi Shimo; Nobuhiko Ohno; Kazuma Mifune; Kenjiro Shimano; Kimiko Yamamoto; Kazuhiko Nozaki; Hidetoshi Kasuya; Shuh Narumiya; Tomohiro Aoki
Journal:  Transl Stroke Res       Date:  2019-02-08       Impact factor: 6.829

Review 9.  Dendritic Cells as an Alternate Approach for Treatment of Neurodegenerative Disorders.

Authors:  Veronika Brezovakova; Bernadeta Valachova; Jozef Hanes; Michal Novak; Santosh Jadhav
Journal:  Cell Mol Neurobiol       Date:  2018-06-13       Impact factor: 5.046

10.  Brain bioavailability of human intravenous immunoglobulin and its transport through the murine blood-brain barrier.

Authors:  Isabelle St-Amour; Isabelle Paré; Wael Alata; Katherine Coulombe; Cassandra Ringuette-Goulet; Janelle Drouin-Ouellet; Milène Vandal; Denis Soulet; Renée Bazin; Frédéric Calon
Journal:  J Cereb Blood Flow Metab       Date:  2013-09-18       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.